Abstract
This mini review aims to outline some of the non testing approaches that are available for the purposes of predicting and assuring drug safety. Focus will be made on several endpoints of specific concern such as ADME properties as well as mutagenicity and carcinogenicity. The use of TTC and chemical categories approaches are presented as alternative strategies. Overall there is great potential to apply a battery of different tools in drug discovery from QSARs to TTC and chemical categories. Greater awareness of other initiatives (in parallel industries) coupled with more practical guidance on how to exploit these tools is still required before they become embedded into routine use.
Keywords: Quantitative structure activity relationships, expert systems, ADME, mutagenicity, carcinogenicity, thresholds of, toxicological concern (TTC), chemical categories
Current Computer-Aided Drug Design
Title: Computational Methods to Predict Drug Safety
Volume: 2 Issue: 2
Author(s): Grace Patlewicz
Affiliation:
Keywords: Quantitative structure activity relationships, expert systems, ADME, mutagenicity, carcinogenicity, thresholds of, toxicological concern (TTC), chemical categories
Abstract: This mini review aims to outline some of the non testing approaches that are available for the purposes of predicting and assuring drug safety. Focus will be made on several endpoints of specific concern such as ADME properties as well as mutagenicity and carcinogenicity. The use of TTC and chemical categories approaches are presented as alternative strategies. Overall there is great potential to apply a battery of different tools in drug discovery from QSARs to TTC and chemical categories. Greater awareness of other initiatives (in parallel industries) coupled with more practical guidance on how to exploit these tools is still required before they become embedded into routine use.
Export Options
About this article
Cite this article as:
Patlewicz Grace, Computational Methods to Predict Drug Safety, Current Computer-Aided Drug Design 2006; 2 (2) . https://dx.doi.org/10.2174/157340906777441735
DOI https://dx.doi.org/10.2174/157340906777441735 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PDZ Domain Protein-Protein Interactions: A Case Study with PICK1
Current Topics in Medicinal Chemistry Carotid Artery Atherosclerosis: What is the Evidence for Drug Action?
Current Pharmaceutical Design Probiotics and Oral Health
Current Pharmaceutical Design Boron Nitride Nanotubes: Production, Properties, Biological Interactions and Potential Applications as Therapeutic Agents in Brain Diseases
Current Nanoscience Serotonin and Cancer: What Is the Link?
Current Molecular Medicine Editorial [ Anti-Angiogenesis Agents Executive Editor: Cezary Marcinkiewicz ]
Current Pharmaceutical Design Design of Lanthanide Complex Probes for Highly Sensitive Time-Resolved Fluorometric Detection Methods and Its Application to Biochemical, Environmental and Clinical Analyses
Current Analytical Chemistry Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders
CNS & Neurological Disorders - Drug Targets Collateral Damage Control in Cancer Therapy: Defining the Stem Identity in Gliomas
Current Pharmaceutical Design Reviewing the Role of Resveratrol as a Natural Modulator of Microglial Activities
Current Pharmaceutical Design Subject Index to Volume 4
Current Topics in Medicinal Chemistry Mass Spectrometric Imaging of the Nervous System
Current Pharmaceutical Design Randomized Controlled Clinical Trials in Mild-Moderate Ulcerative Colitis
Reviews on Recent Clinical Trials Cytokines Play a Key Role in Communication between Mesenchymal Stem Cells and Brain Cancer Cells
Protein & Peptide Letters Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Current Genomics The Regulation of miRNAs in Inflammation-Related Carcinogenesis
Current Pharmaceutical Design Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) Neonatal Fc Receptor and its Role in the Absorption, Distribution, Metabolism and Excretion of Immunoglobulin G-Based Biotherapeutics
Current Drug Metabolism Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology
Current Drug Targets Does the MK2-dependent Production of TNFα Regulate mGluR-dependent Synaptic Plasticity?
Current Neuropharmacology